Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1340P encodes a pseudogene copy of the small nuclear RNA U6, labeled by its locus. U6 small nuclear RNA is involved in the spliceosome complex required for pre-mRNA splicing, but the RNU6-1340P locus is not transcribed or functional for this activity. Instead, it represents a processed pseudogene formed via L1 retrotransposition, a process by which enzyme machinery retrocopies and inserts noncoding RNA fragments elsewhere in the genome[2]. These pseudogenes lack regulatory elements and are not spliced, transcribed, or translated into proteins. No evidence currently supports a functional, regulatory, or disease-related role for RNU6-1340P. It is a marker of historical retrotransposition events[2][3]. Its only established significance is as a genomic landmark of retrotranspositional activity and genome architecture[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1340, pseudogene (RNU6-1340P).